From: Limitations of diabetes pharmacotherapy: results from the Vermont Diabetes Information System study
Characteristic | N = 1006 |
---|---|
Age in years, median (range) | 65 (22–93) |
Sex, % female | 54% |
Race (% White) | 97% |
Education (high school graduate), % | 75% |
Smoking, % | 17% |
Income (< $30,000/y), % | 59% |
Insurance (subjects may have dual coverage) | Â |
   Private | 58% |
   Medicare | 60% |
   Medicaid | 21% |
   Military | 2% |
   None | 5% |
Medication covered by insurance | Â |
   None | 12% |
   Partial | 72% |
   Full | 16% |
Duration of DM, years, median (range) | 6.7 (0.2–62) |
BMI | Â |
   Normal (BMI < 25) | 10% |
   Overweight (BMI 25–29.9) | 23% |
   Obese (BMI >= 30) | 67% |
A1C %, mean (SD) | 7.1 (1.3) |
A1C in excellent control [<7%], % | 57% |
Excellent BP control (<= 130/80), % | 25% |
Poor BP control (>140/90), % | 51% |
SF-12 PCS, mean (SD) | 41 (12) |
SF-12 MCS, mean (SD) | 50 (11) |
Total prescription medications, median(range) | 6 (0–24) |